| Pfizer AG - Rapamune 0.5 mg, überzogene Tabletten | | 55804 | | 03 | | Rapamune 0.5 mg | | überzogene Tabletten | | L04AA10 | | Sirolimus | | 15.02.2011 | | |
| | Composition | | sirolimusum 0.5 mg, poloxamerum 188, lactosum monohydricum 86.4 mg, macrogolum 8000, magnesii stearas, talcum, macrogolum 20'000, glyceroli mono-oleas, lacca, calcii sulfas anhydricus, cellulosum microcristallinum, saccharum 213.7 mg, povidonum K 29-32, int-rac-alpha-tocopherylis acetas, E 171, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), cera carnauba, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro compresso obducto. | | Packungsbestandteile | | überzogene Tabletten | | | | | Active Agent | Dose |
|---|
| Sirolimus | 0.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Sirolimus | 0.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Calcii Sulfas Anhydricus | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | | | E 171 | | color. | | E 172 | | color. | | Glyceroli Mono-Oleas | | | | Int-Rac-Alpha-Tocopherylis Acetas | | | | Lacca | | Drucktinte | | Lactosum Monohydricum | 86.4 mg | | | Macrogolum | 20000 | | | Magnesii Stearas | | | | Poloxamerum | 188 | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Propylenglycolum | | | | Saccharum | 213.7 mg | | | Simeticonum | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 008 | 30 Tablette(n) | 63.87 | 85.90 | B | SL | No | | 009 | 100 Tablette(n) | PR | PR | B | | Yes |
|
|
